WINDLAS BIOTECH
|
WINDLAS BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 20.37 | 17.48 | 24.70 | 25.29 | 99.55 |
CEPS(Rs) | 26.28 | 23.05 | 15.77 | 18.11 | 41.29 |
DPS(Rs) | 4.00 | 3.50 | - | - | - |
Book NAV/Share(Rs) | 190.89 | 180.31 | 310.59 | 327.03 | 301.96 |
Tax Rate(%) | 25.27 | 16.41 | 28.16 | 26.31 | 15.99 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 11.74 | 11.25 | 12.79 | 12.61 | 12.53 |
EBIT Margin(%) | 11.27 | 10.08 | 5.43 | 10.54 | 26.60 |
Pre Tax Margin(%) | 11.12 | 9.78 | 5.12 | 9.77 | 25.02 |
PAT Margin (%) | 8.31 | 8.17 | 3.68 | 7.20 | 21.02 |
Cash Profit Margin (%) | 10.72 | 10.78 | 6.71 | 10.03 | 24.47 |
Performance Ratios | |||||
ROA(%) | 8.39 | 9.70 | 4.97 | 7.45 | 22.01 |
ROE(%) | 10.76 | 12.87 | 7.70 | 11.74 | 40.92 |
ROCE(%) | 14.39 | 14.88 | 9.93 | 15.05 | 40.49 |
Asset Turnover(x) | 1.01 | 1.19 | 1.35 | 1.03 | 1.05 |
Sales/Fixed Asset(x) | 2.87 | 2.68 | 3.24 | 4.01 | 3.26 |
Working Capital/Sales(x) | 2.21 | 1.62 | 4.24 | 7.69 | 12.67 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.35 | 0.37 | 0.31 | 0.25 | 0.31 |
Receivable days | 80.97 | 74.49 | 61.18 | 69.74 | 76.22 |
Inventory Days | 47.47 | 39.24 | 38.74 | 37.93 | 32.12 |
Payable days | 92.18 | 64.78 | 85.92 | 121.67 | 138.62 |
Valuation Parameters | |||||
PER(x) | 11.06 | 12.02 | - | - | - |
PCE(x) | 8.57 | 9.11 | - | - | - |
Price/Book(x) | 1.18 | 1.17 | - | - | - |
Yield(%) | 1.78 | 1.67 | - | - | - |
EV/Net Sales(x) | 0.87 | 0.75 | 0.02 | 0.05 | 0.08 |
EV/Core EBITDA(x) | 6.36 | 5.92 | 0.11 | 0.35 | 0.54 |
EV/EBIT(x) | 7.72 | 7.45 | 0.29 | 0.45 | 0.28 |
EV/CE(x) | 0.85 | 0.72 | 0.02 | 0.05 | 0.08 |
M Cap / Sales | 0.92 | 0.98 | - | - | - |
Growth Ratio | |||||
Net Sales Growth(%) | 10.12 | 8.96 | 30.03 | 7.02 | -12.76 |
Core EBITDA Growth(%) | 18.71 | 2.33 | 31.47 | 2.78 | -1.78 |
EBIT Growth(%) | 23.08 | 102.48 | -33.06 | -57.59 | 211.98 |
PAT Growth(%) | 11.91 | 141.94 | -33.51 | -63.34 | 483.25 |
EPS Growth(%) | 16.55 | -29.23 | -2.35 | -74.60 | 396.78 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | - | 0.02 | 0.16 | 0.13 | 0.15 |
Current Ratio(x) | 2.92 | 4.06 | 2.08 | 1.34 | 1.25 |
Quick Ratio(x) | 2.30 | 3.44 | 1.64 | 0.95 | 1.05 |
Interest Cover(x) | 73.38 | 33.16 | 17.99 | 13.72 | 16.89 |
Total Debt/Mcap(x) | - | 0.01 | - | - | - |
Compare Financial Ratios of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,065.7 Cr | 2.3% | -5% | 120.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹388,812.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹120,673.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,679.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,152.0 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹91,234.9 Cr | -1.6% | -7% | 23.8% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | 2.3% |
-5% |
120.3% |
SENSEX | -0.4% |
-0.9% |
25.8% |
You may also like the below Video Courses